Loading…
Based on limited metadata, this FDA Warning Letter was issued to Degasa S.A. De C.V. on April 18, 2018, regarding a product classified as "Other," though the specific product category and detailed violations are not available in the provided information. Without access to the full letter text or a defined subject line, the exact nature of the regulatory concerns cannot be determined. The issuing office information is also unavailable, limiting visibility into which FDA division initiated this action. Additional documentation would be needed to identify the specific violations and applicable regulatory requirements.